In addition, Bowtell and his colleagues showed that two molecular subsets underlies platinum resistance in ovarian cancer: in one subset, cyclin E amplification is associated with platinum resistance, and in another subset without cyclin E amplification, enrichment of cell adhesion, and ECM pathways are associated with platinum resistance (23). This evidence concerns the gene CCNE1 and ovarian cancer.